Abstract:Currently, multi-drug resistance (MDR) to antineoplastic drugs is a major obstacle to successful treatment of carcinoma. Looking for novel agents with anti-MDR activity is an effectively way to overcome cancer drug resistance. Our previous study showed that podophyllotoxin derivative exhibited potent anti-proliferative effect and down-regulated the expression level of P-gp in K562/ADR cells, which probably was related with the MAPK pathways. However, the relation of P-gp expression and MAPK pathways still remains unclear. In this study, a series of aromatic heterocyclic esters of podophyllotoxin were synthesized and their anticancer effects were evaluated against two human chronic myeloid leukemia cell lines (K562 and K562/ADR), simultaneously, the initial structure-activity relationship was summarized. The most potent compound, Z5, displayed an IC50 value of 0.032 ± 0.006 μM against K562/ADR cells, with a lower resistant factor value of 1.280. Treatment of K562/ADR cells with Z5 caused S cell cycle arrest through reductions in cyclinA, cyclinB1, CDK1 and CDK2 levels. Moreover, Z5 treatment resulted in the induction of apoptosis as characterized by DNA staining, flow cytometry analysis and cleavage of procaspases-3, -8, -9 and PARP. Notably, Z5 significantly inhibited P-gp expression in K562/ADR cells. Additionally, Z5 also caused reactive oxygen species (ROS) generation, which was further demonstrated by preincubation with the antioxidant N-acetylcysteine (NAC). Western blotting revealed that Z5 markedly stimulated the MAPK pathways, including ERK1/2, JNK and P38, however, the mechanisms were prevented by NAC. Finally, the employment of NAC and MAPK inhibitors (U0126, SP600125 and SB203580) remarkably blocked the S phase arrest, apoptosis and down-regulation of P-gp induced by Z5. Taken together, Z5 strongly possessed the potential anti-MDR activity in K562/ADR cells through ROS/MAPK pathways-dependent S phase arrest, apoptosis and down-regulation of P-gp expression.

Aromatic Heterocyclic Esters of Podophyllotoxin Exert Anti-Mdr Activity in Human Leukemia K562/ADR Cells Via ROS/MAPK Signaling Pathways

Potential anti-MDR agents based on the podophyllotoxin scaffold: synthesis and antiproliferative activity evaluation against chronic myeloid leukemia cells by activating MAPK signaling pathways

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Design, Synthesis and Evaluation of the Multidrug Resistance-Reversing Activity of Pyridine Acid Esters of Podophyllotoxin in Human Leukemia Cells

Synthesis and Biological Evaluation of Novel Podophyllotoxin-Nsaids Conjugates As Multifunctional Anti-Mdr Agents Against Resistant Human Hepatocellular Carcinoma Bel-7402/5-FU Cells

Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.

Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance

Design, Synthesis, and Biological Evaluation of Indole Carboxylic Acid Esters of Podophyllotoxin As Antiproliferative Agents

Design, Synthesis and Antineoplastic Activity of Novel Hybrids of Podophyllotoxin and Indirubin Against Human Leukaemia Cancer Cells As Multifunctional Anti-Mdr Agents.

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

GMZ-1 is a Podophyllotoxin Derivative That Suppresses Growth and Induces Apoptosis in Adriamycin-Resistant K562/A02 Cells Through Modulation of MDR1 Expression.

Design, Synthesis and Biological Evaluation of Novel Nitric Oxide-Donating Podophyllotoxin Derivatives As Potential Antiproliferative Agents Against Multi-Drug Resistant Leukemia Cells

Synthesis and Evaluation of Substituted Dibenzo[c,e]azepine-5-ones As P-glycoprotein-mediated Multidrug Resistance Reversal Agents

A Novel Compound RY10-4 Downregulates P-glycoprotein Expression and Reverses Multidrug-Resistant Phenotype in Human Breast Cancer MCF-7/ADR Cells.

Antiproliferative Effect of ZSTK474 Alone or in Combination with Chemotherapeutic Drugs on HL60 and HL60/ADR Cells

Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties

Antimultidrug-Resistant Effect and Mechanism of A Novel Ca-4 Analogue Mz3 on Leukemia Cells

Design and Synthesis of Piperazine Acetate Podophyllotoxin Ester Derivatives Targeting Tubulin Depolymerization As New Anticancer Agents.

Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells.

Reversion of Drug-Resistance and Induction of Apoptosis by Podophyllotoxin Nanoliposome in Human Leukemia Multidrug-Resistant Cells

The Bisbenzylisoquinoline Alkaloids, Tetrandine and Fangchinoline, Enhance the Cytotoxicity of Multidrug Resistance-Related Drugs Via Modulation of P-glycoprotein.